{"id":91161,"date":"2019-11-27T11:09:45","date_gmt":"2019-11-27T16:09:45","guid":{"rendered":"https:\/\/pulmonx.com\/references\/"},"modified":"2025-01-27T15:55:44","modified_gmt":"2025-01-27T20:55:44","slug":"references","status":"publish","type":"page","link":"https:\/\/pulmonx.com\/uk-en\/references\/","title":{"rendered":"References"},"content":{"rendered":"

 <\/p>\r\n\r\n\n

\n
\n
\n
\n \n
\n
\n

References<\/h1>\n
    \n
  1. Criner, GJ, Sue, R, Wright, S, Dransfield, M, Rivas-Perez, H, Wiese, T & Morrissey, B. A multicenter randomized control trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med, 2018;198(9), 1151-1164, and data on file at Pulmonx.<\/li>\n
  2. Kemp, SV, Slebos, DJ, Kirk, A, Kornaszewska, M, Carron, K, Ek, L & Briault, A. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med, 2017;196(12), 1535-1543.<\/li>\n
  3. Valipour, A, Slebos, DJ, Herth, F, Darwiche, K, Wagner, M, Ficker, JH, & Eberhardt, R. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study. Am J Respir Crit Care Med, 2016;194(9), 1073-1082, and data on file at Pulmonx.<\/li>\n
  4. Klooster, K, ten Hacken, NH, Hartman, JE, Kerstjens, HA, van Rikxoort, EM & Slebos, DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med, 2015;373(24), 2325-2335.<\/li>\n
  5. Klooster, K, Hartman, JE, ten Hacken, NH, Slebos, DJ. One-year follow-up after endobronchial valve treatment in patients with emphysema without collateral ventilation treated in the STELVIO trial. Respir 2017; 93(2), 112-121.<\/li>\n
  6. Koster, TD, Van Rikxoort, EM, Huebner, RH, Doellinger, F, Klooster, K, & Charbonnier, JP. Predicting lung volume reduction after endobronchial valve therapy is maximized using a combination of diagnostic tools. Respiration, 2016; 92(3), 150\u2013157.<\/li>\n
  7. Ruwwe-Gl\u00f6senkamp, C, Dorothea, T, D\u00f6llinger, F, Temmesfeld-Wollbruck, TW, Hippenstiel, S, Norbert, S & Huebner, RH. Characterization of Chartis Phenotypes based on fissure completeness scores. Eur Respir J, 2018.<\/li>\n
  8. Mansfield C, Sutphin J, Shriner K, Criner GJ, Celli BR. Patient preferences for endobronchial valve treatment of severe emphysema. Chronic Obstr Pulm Dis. 2019;6(1). doi: https:\/\/doi.org\/10.15326\/jcopdf.6.1.2018.0147<\/a><\/li>\n
  9. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2017. Available from: http:\/\/goldcopd.org<\/a>.<\/li>\n
  10. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020. Available from: http:\/\/goldcopd.org<\/a>.<\/li>\n
  11. NICE (National Institute for Health and Care Excellence) Final Guidance on Endobronchial valve insertion to reduce lung volume in emphysema (https:\/\/www.nice.org.uk\/guidance\/ipg600), accessed Dec. 20, 2017.<\/li>\n
  12. German Respiratory Society (DGP) and Austrian Respiratory Society (OGP) Vogelmeier, C, Buhl, R, Burghuber, O, Criee, CP, Ewig, S, Godnic-Cvar, J, & Nowak, D. Guideline for the diagnosis and treatment of COPD patients-issued by the German respiratory society and the German Atemwegsliga in cooperation with the Austrian Society of Pneumology. Pneumologie (Stuttgart, Germany), 2018;72(4), 253-308.<\/li>\n
  13. National Health Care Institute of the Netherlands: Richtlijn Ketenzorg COPD. Dekhuijzen, PNR, Smeele, IJM,\u00a0 Smorenburg, SM, and Verhoeven, MAWM. 2005. Leusden, Stichting Ketenkwaliteit COPD.<\/li>\n
  14. Lakerveld-Heyl, K, RMM, Geijer, R, Gosselink, J, Muris, MA, Vermeeren, W Van Hensbergen, MCE, Verhoef-van Wijk, S, Flikweert, & CD, Van Ravensberg, 2007. 104 Landelijke Eerstelijns Samenwerkings Afspraak COPD. Huisarts en Wetenschap 50:S21-S27.<\/li>\n
  15. van Agteren, JE, Hnin, K, Grosser, D, Carson, KV & Smith, BJ. Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease. The Cochrane Library, 2017.<\/li>\n
  16. Davey, C, Zoumot, Z, Jordan, S, McNulty, WH, Carr, DH, Hind, MD, Shah, PL. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial.\u00a0Lancet,\u00a02015;386(9998), 1066-1073.<\/li>\n
  17. Sciurba, FC, Ernst, A, Herth, FJ, Strange, C, Criner, GJ, Marquette, CH, McLennan, G. A randomized study of endobronchial valves for advanced emphysema.\u00a0N Engl J Med, 2010;363(13), 1233-1244.<\/li>\n
  18. Slebos, DJ, Shah, PL, Herth, FJ & Valipour, A. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from expert panel on endoscopic lung volume reduction. Respir, 2017;93(2), 138-150.<\/li>\n
  19. Herth, FJ, Noppen, M, Valipour, A, Leroy, S, Vergnon, JM, Ficker, JH & Ernst, A. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Euro Respir J, 2012;39(6), 1334-1342.<\/li>\n
  20. Food and Drug Admistration (FDA), Summary of Safety and Effectiveness document for the Pulmonx Zephyr Endobronchial Valve System, June 29, 2018 (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/P180002B.pdf<\/a>).<\/li>\n
  21. Raherison, C, & Girodet, PO. Epidemiology of COPD. Euro Respir Review, 2009;18(114), 213-221.<\/li>\n
  22. Quaderi, SA & Hurst, JR. The unmet global burden of COPD. Glob\u00a0Health<\/span> Epidemiol Genom,2018; doi:10.1017\/gheg.2018.<\/li>\n
  23. Habraken, JM, ter Riet, G, Gore, JM, Greenstone, MA, Weersink, EJ, Bindels, PJ, & Willems, DL. Health-related quality of life in end-stage COPD and lung cancer patients. J Pain\u00a0Symptom Manage, 2009;37<\/i>(6), 973-981.<\/li>\n
  24. Wilson, L, Devine, EB, & So, K. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir Med, 2000;94(3), 204-213.<\/li>\n
  25. Ford, ES, Murphy, LB, Khavjou, O, Giles, WH, Holt, JB, & Croft, JB. Total and state-specific medical and absenteeism costs of COPD among adults aged 18 years in the United States for 2010 and projections through 2020. Chest, 2015;147(1), 31-45 and Pulmonx analysis.<\/li>\n
  26. Soriano, JB, Abajobir, AA, Abate, KH, Abera, SF, Agrawal, A, Ahmed, MB, Alam, N. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma<\/a>, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015.\u00a0Lancet Respir Med, 2017;\u00a05(9), 691-706.<\/li>\n
  27. Wheaton, AG, Cunningham, TJ, Ford, ES, Croft, JB. Employment and activity limitations among adults with chronic obstructive pulmonary disease\u2014United States, 2013.\u00a0MMWR Morb Mortal Wkly Rep, 2015;64(11), 289.<\/li>\n
  28. Ford, ES, Murphy, LB, Khavjou, O, Giles, WH, Holt, JB, Croft, JB. Total and state-specific medical and absenteeism costs of COPD among adults aged 18 years in the United States for 2010 and projections through 2020.<\/a>\u00a0Chest, 2015;\u00a0147(1), 31-45.<\/li>\n
  29. Casanova, C, Cote, C, De Torres, JP, Aguirre-Jaime, A, Marin, JM, Pinto-Plata, V, Celli, BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.\u00a0Am J Respir Crit Care Med,\u00a02005;171<\/i>(6), 591-597.<\/li>\n
  30. National Center for Health Statistics. Summary health statistics: National Health Interview Survey<\/a>, 2018.<\/li>\n
  31. Soriano, JB., Lamprecht, B, Ramirez, AS, Martinez-Camblor, P, Kaiser, B, Alfageme, I. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med, 2015; 3: 443-50.\u00a0BMC Pulm Med,\u00a014, 163.<\/li>\n
  32. Wilson, DO, Weissfeld, JL, Balkan, A, Schragin, JG, Fuhrman, CR, Fisher, SN, Sciurba, FC. Association of radiographic emphysema and airflow obstruction with lung cancer.\u00a0Am J Respir Crit Care Med,\u00a02008;178(7), 738-744.<\/li>\n
  33. Tian, Q, Qi, F, An, Y, Liu, XC, Chen, LA. Using the Chartis system to selectively target a lung segment with a persistent air leak.<\/a>\u00a0Euro Respir J,\u00a02013;41(6), 1461-1463.<\/li>\n
  34. NICE (National Institute for Health and Care Excellence) Chronic obstructive pulmonary disease in over 16s: diagnosis and management (https:\/\/www.nice.org.uk\/guidance\/NG115<\/a>), accessed February 27, 2020.<\/li>\n
  35. \n

    Criner, GJ, Delage, A, Voelker, K, Hogarth, DK, et al. Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. Am J Respir Crit Care Med, 2019; 200(11), 1354\u20131362.<\/p>\n<\/li>\n

  36. \n

    Li S, Wang G, Wang C, Gao X, Jin F, Yang H, Han B, Zhou R, Chen C, Chen L, Bai C, Shen H, Herth FJF, Zhong N. The REACH Trial: A
    Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration Valve System in the Treatment of Severe Emphysema. Respir, 2019; 97(5), 416\u2013427.<\/p>\n<\/li>\n

  37. Dransfield, M, Garner, JL, Bhatt, SP, Slebos, DJ, Klooster, K, Sciurba, FC, Shah, PL, Marchetti, NT, Sue, RD, Wright, S, Rivas-Perez, H, Wiese, TA, Wahidi, MM, de Oliveira, HG, Armstrong, B, Radhakrishnan, S, Shargill, NS, Criner, GJ; for the LIBERATE Study Group, Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year Results from a Randomized Clinical Trial. Ann Am Thorac Soc. 2020; 17(7): 829\u2013838.<\/li>\n
  38. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023. Available from: http:\/\/goldcopd.org.<\/a><\/li>\n
  39. Hartman, JE, Klooster K, Ten Hacken NH, van Dijk, M, Slebos DJ. Patient satisfaction and attainment of patient-specific goals after endobronchial valve treatment. Am Thoracic Society. 2021:18(1), 68-74.<\/li>\n
  40. van der Molen MC, Hartman JE, Vanfleteren LEGW, Kerstjens HAM, van Melle JP, Willems TP, Slebos DJ. Reduction of Lung Hyperinflation Improves Cardiac Preload, Contractility, and Output in Emphysema: A Clinical Trial in Patients Who Received Endobronchial Valves. Am J Respir Crit Care Med. 2022 Sep 15;206(6):704-711. doi: 10.1164\/rccm.202201-0214OC. PMID: 35584341.<\/li>\n
  41. Hartman JE, Welling JBA, Klooster K, Carpaij OA, Augustijn SWS, Slebos DJ. Survival in COPD patients treated with bronchoscopic lung volume reduction. Respir Med. 2022 May;196:106825. doi: 10.1016\/j.rmed.2022.106825. Epub 2022 Mar 16. PMID: 35325741.<\/li>\n
  42. Zephyr Valve Instructions for Use.<\/li>\n
  43. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2023.<\/li>\n
  44. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2024.<\/li>\n<\/ol> <\/div>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n","protected":false},"excerpt":{"rendered":"

     <\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-91161","page","type-page","status-publish","hentry","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"acf":[],"yoast_head":"\nReferences Page | Pulmonx<\/title>\n<meta name=\"description\" content=\"Read the References page of the Pulmonx UK site to see what scholarly sources the company cites throughout the website.\" \/>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"References Page | Pulmonx\" \/>\n<meta property=\"og:description\" content=\"Read the References page of the Pulmonx UK site to see what scholarly sources the company cites throughout the website.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pulmonx.com\/uk-en\/references\/\" \/>\n<meta property=\"og:site_name\" content=\"Pulmonx\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Mylungsmylife\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-27T20:55:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2021\/08\/COPD-Technology-Zephyr-Valve-Social-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1700\" \/>\n\t<meta property=\"og:image:height\" content=\"920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@my_lungs\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/references\\\/\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/references\\\/\",\"name\":\"References Page | Pulmonx\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/#website\"},\"datePublished\":\"2019-11-27T16:09:45+00:00\",\"dateModified\":\"2025-01-27T20:55:44+00:00\",\"description\":\"Read the References page of the Pulmonx UK site to see what scholarly sources the company cites throughout the website.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/references\\\/#breadcrumb\"},\"inLanguage\":\"en-UK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/references\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/references\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"References\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/#website\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/\",\"name\":\"Pulmonx\",\"description\":\"Helping Patients with COPD Breathe Easier\",\"publisher\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-UK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/#organization\",\"name\":\"Pulmonx Corporation\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-UK\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/Logo-RGB.png\",\"contentUrl\":\"https:\\\/\\\/pulmonx.com\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/Logo-RGB.png\",\"width\":566,\"height\":217,\"caption\":\"Pulmonx Corporation\"},\"image\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/uk-en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Mylungsmylife\",\"https:\\\/\\\/x.com\\\/my_lungs\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pulmonx\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCOcSdewvx6iquPm_XcaYI5Q\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"References Page | Pulmonx","description":"Read the References page of the Pulmonx UK site to see what scholarly sources the company cites throughout the website.","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"References Page | Pulmonx","og_description":"Read the References page of the Pulmonx UK site to see what scholarly sources the company cites throughout the website.","og_url":"https:\/\/pulmonx.com\/uk-en\/references\/","og_site_name":"Pulmonx","article_publisher":"https:\/\/www.facebook.com\/Mylungsmylife","article_modified_time":"2025-01-27T20:55:44+00:00","og_image":[{"width":1700,"height":920,"url":"https:\/\/pulmonx.com\/wp-content\/uploads\/2021\/08\/COPD-Technology-Zephyr-Valve-Social-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@my_lungs","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pulmonx.com\/uk-en\/references\/","url":"https:\/\/pulmonx.com\/uk-en\/references\/","name":"References Page | Pulmonx","isPartOf":{"@id":"https:\/\/pulmonx.com\/uk-en\/#website"},"datePublished":"2019-11-27T16:09:45+00:00","dateModified":"2025-01-27T20:55:44+00:00","description":"Read the References page of the Pulmonx UK site to see what scholarly sources the company cites throughout the website.","breadcrumb":{"@id":"https:\/\/pulmonx.com\/uk-en\/references\/#breadcrumb"},"inLanguage":"en-UK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pulmonx.com\/uk-en\/references\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pulmonx.com\/uk-en\/references\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pulmonx.com\/uk-en\/"},{"@type":"ListItem","position":2,"name":"References"}]},{"@type":"WebSite","@id":"https:\/\/pulmonx.com\/uk-en\/#website","url":"https:\/\/pulmonx.com\/uk-en\/","name":"Pulmonx","description":"Helping Patients with COPD Breathe Easier","publisher":{"@id":"https:\/\/pulmonx.com\/uk-en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pulmonx.com\/uk-en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-UK"},{"@type":"Organization","@id":"https:\/\/pulmonx.com\/uk-en\/#organization","name":"Pulmonx Corporation","url":"https:\/\/pulmonx.com\/uk-en\/","logo":{"@type":"ImageObject","inLanguage":"en-UK","@id":"https:\/\/pulmonx.com\/uk-en\/#\/schema\/logo\/image\/","url":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Logo-RGB.png","contentUrl":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Logo-RGB.png","width":566,"height":217,"caption":"Pulmonx Corporation"},"image":{"@id":"https:\/\/pulmonx.com\/uk-en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Mylungsmylife","https:\/\/x.com\/my_lungs","https:\/\/www.linkedin.com\/company\/pulmonx","https:\/\/www.youtube.com\/channel\/UCOcSdewvx6iquPm_XcaYI5Q"]}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Pulmonx","distributor_original_site_url":"https:\/\/pulmonx.com\/uk-en\/","push-errors":false,"_links":{"self":[{"href":"https:\/\/pulmonx.com\/uk-en\/wp-json\/wp\/v2\/pages\/91161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pulmonx.com\/uk-en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pulmonx.com\/uk-en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pulmonx.com\/uk-en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pulmonx.com\/uk-en\/wp-json\/wp\/v2\/comments?post=91161"}],"version-history":[{"count":0,"href":"https:\/\/pulmonx.com\/uk-en\/wp-json\/wp\/v2\/pages\/91161\/revisions"}],"wp:attachment":[{"href":"https:\/\/pulmonx.com\/uk-en\/wp-json\/wp\/v2\/media?parent=91161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}